Advertisement
Advertisement

PRCT

PRCT logo

PROCEPT BioRobotics Corporation Common Stock

19.15
USD
Sponsored
-0.16
-0.83%
Jul 15, 16:00 UTC -4
Closed
exchange

After-Market

19.11

-0.04
-0.23%

PRCT Earnings Reports

Positive Surprise Ratio

PRCT beat 11 of 19 last estimates.

58%

Next Report

Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
$94.63M
/
-$0.46
Implied change from Q1 26 (Revenue/ EPS)
+13.83%
/
-17.86%
Implied change from Q2 25 (Revenue/ EPS)
+19.50%
/
+31.43%

PROCEPT BioRobotics Corporation Common Stock earnings per share and revenue

On Apr 29, 2026, PRCT reported earnings of -0.56 USD per share (EPS) for Q1 26, beating the estimate of -0.56 USD, resulting in a 1.34% surprise. Revenue reached 83.13 million, compared to an expected 82.12 million, with a 1.24% difference. The market reacted with a +10.73% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 14 analysts forecast an EPS of -0.46 USD, with revenue projected to reach 94.63 million USD, implying an decrease of -17.86% EPS, and increase of 13.83% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
Jul 14, 2026 For Q4 26
Estimate
-$0.09
Actual
-$0.07
Surprise
+23.75%
FAQ
For Q1 2026, PROCEPT BioRobotics Corporation Common Stock reported EPS of -$0.56, beating estimates by 1.34%, and revenue of $83.13M, 1.24% above expectations.
The stock price moved up 10.73%, changed from $21.71 before the earnings release to $24.04 the day after.
The next earning report is scheduled for Aug 04, 2026.
Based on 14 analysts, PROCEPT BioRobotics Corporation Common Stock is expected to report EPS of -$0.46 and revenue of $94.63M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement